Daniel Relton

Daniel specialises in a wide range of commercial contracts across the healthcare, technology and telecommunications sectors and regularly assists on large M&A transactions, particularly in a carve-out context, advising on and negotiating the ancillary agreements relating to the same - including transitional services, distribution, manufacturing, and supply arrangements. During a six-month secondment to Baker McKenzie’s Tokyo office, Daniel advised Yildiz Holding and GODIVA Chocolatier on the sale of its retail and distribution operations in Japan, South Korea, Australia, and New Zealand.

Daniel’s practice also extends to advising on contentious and advisory matters in the TMT sector.

• Advising GSK on contractual separation matters related to the spinning out of their consumer healthcare division, Haleon. 
• Advising Sandoz on ancillary manufacturing, supply and distribution arrangements resulting from their USD 100 million divestment of Sandoz China to Aspen and the EUR 55.5 million acquisition of commercialisation rights in Europe to certain Aspen aesthetic products.
• Advising a large multinational biopharmaceutical company on the creation of 3PL and 4PL template agreements and updates to their voluntary licensing programme. 
• Advising Colt Technology Services on their USD 1.8 billion acquisition of Lumen's EMEA business. 
• Advising Olam Group on the separation and listing of their food ingredients business. 
• Advising a software payments provider on an arbitration relevant to a project dispute with a central bank. 
• Advising a telecommunications provider on a dispute and mediation arising from the insolvency of a key customer. 
• Advising blue-chip technology companies on multijurisdictional rollouts of new product initiatives and responses to regulatory changes, including matters arising from digital services taxes. 
• Advising a broadcaster on Ofcom Broadcasting Code sanctions and related judicial review proceedings.

• Society for Computers and Law